A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/55 (2006.01) A61P 9/00 (2006.01)
Patent
CA 2404120
The present invention relates to the new use of bradycardiac substances such as a Ca++ channel blocker, beta-receptor blocker or i f channel blocker, the i f channel blockers being preferred, optionally in combination with a cardioactive substance for inducing the regression of myocardial diseases accompanied by hypertrophy, particularly for the treatment of idiopathic hypertrophic cardiomyopathies (HCM) in humans and domestic pets.
La présente invention concerne une utilisation nouvelle de substances bradycardiques telles qu'un bloquant de canal Ca<++>, des bloquants de béta-récepteurs, ou des bloquants de canal if, les bloquants de canal if étant les bloquants préférés. Lesdites substances bradycardiques peuvent être utilisées en combinaison avec une substance agissant sur le coeur de manière à provoquer une régression de maladies cardiaques accompagnées d'hypertrophie, en particulier pour le traitement de cardiomyopathies idiopathiques hypertrophiques (HCM) chez l'homme et les animaux domestiques.
Dammgen Jurgen
Guth Brian
Seidler Randolph
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Boehringer Ingelheim Pharma Kg
Fetherstonhaugh & Co.
LandOfFree
Use of bradycardiac agents in the treatment of myocardial... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of bradycardiac agents in the treatment of myocardial..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of bradycardiac agents in the treatment of myocardial... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1377240